SDB-006 N-phenyl analog is primarily studied for its potential applications in pharmacological research, particularly in the field of cannabinoid receptor modulation. Its structural similarity to certain cannabinoid compounds makes it a candidate for investigating interactions with cannabinoid receptors, which could lead to insights into pain management, inflammation, and neurological disorders. Researchers are exploring its efficacy in preclinical models to assess its therapeutic potential, especially in conditions where cannabinoid receptor activity plays a critical role. Additionally, its unique chemical properties may contribute to the development of novel compounds for targeted drug therapies.